Creative Medical Technology Holdings, Inc. (CELZ) stock
CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.48−0.04 (-8.36%)
Close on Nov 17, 2026Market cap $3.14MP/E –Yield –
Creative Medical Technology pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Creative Medical Technology's pe ratio was 6.2× on Apr 29, 2022.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Apr 29, 2022 | 6.2× | – |
See a number that looks wrong?